dacarbazine has been researched along with Nausea in 59 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (27.12) | 18.7374 |
| 1990's | 9 (15.25) | 18.2507 |
| 2000's | 17 (28.81) | 29.6817 |
| 2010's | 17 (28.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, YG; Song, Y; Wang, HW; Xu, ZK | 1 |
| Barbaro, B; Barone, C; Basso, M; Calegari, MA; Camarda, F; Cassano, A; Cenci, T; de Pascalis, I; Gori, S; Inno, A; Larocca, LM; Martini, M; Monterisi, S; Orlandi, A; Santini, D; Tonini, G | 1 |
| Amatu, A; Belotti, A; Bencardino, K; Cassingena, A; Chirico, G; Esposito, A; Esteller, M; Moutinho, C; Nichelatti, M; Rusconi, F; Sartore-Bianchi, A; Siena, S | 1 |
| Keating, RF; Puscasiu, E; Rood, BR; Yeo, KK | 1 |
| Guo, JX; Huang, XE; Liu, J; Liu, YC; Wei, W; Xiao, Y | 1 |
| Bae, SH; Cho, SY; Kim, CY; Kim, TM; Kim, YH; Kim, YJ; Lee, MM; Lee, SH; Park, CK; Park, MJ | 1 |
| Akutsu, H; Ishikawa, E; Matsuda, M; Matsumura, A; Nakai, K; Onuma, K; Yamamoto, T | 1 |
| Chamberlain, MC; Cloughesy, T; Desjardins, A; Glantz, M; Mikkelsen, T; Reardon, DA; Schiff, D; Wen, PY | 1 |
| Ishikawa, M; Oashi, K | 1 |
| Hong, YS; Jeong, JH; Kim, J; Kim, JC; Kim, JE; Kim, JH; Kim, KP; Kim, SY; Kim, TW; Lim, SB; Park, IJ; Park, JH; Park, Y; Yu, CS | 1 |
| Akutsu, H; Ishikawa, E; Matsuda, M; Matsumura, A; Takano, S; Yamamoto, T | 1 |
| Dario, A; Tomei, G | 1 |
| Chang, KP; Hsu, TR; Wang, CH; Wong, TT | 1 |
| Hop, WC; Jeurissen, FJ; Roon, K; Taphoorn, MJ; Vecht, CJ; Zwinkels, H | 1 |
| Dinter, DJ; Hohenberger, P; Jakob, J; Ströbel, P; Wenz, F | 1 |
| Hwu, WJ; Patel, SP; Trinh, VA | 1 |
| Abutarif, MA; Cantillon, M; Cutler, D; Diez, BD; Kantesaria, B; Ottaviano, FH; Pallotta, MG; Schwarz, M; Statkevich, P; Xuan, F; Zhu, Y | 1 |
| Bria, E; Corona, M; Fabi, A; Lanzetta, G; Minniti, G; Nardoni, C; Restuccia, MR; Rozzi, A | 1 |
| Chen, ZP; Jiang, XB; Mu, YG; Sai, K; Shen, D; Yang, QY; Zhang, XH | 1 |
| Alterini, R; Bosi, A; Carrai, V; Caruso, JP; Landi, C; Perrone, T; Puccini, B; Rigacci, L | 1 |
| Chow, W; Chung, V; Cristea, M; Frankel, P; Koehler, S; Leong, L; Lim, D; Martel, C; Morgan, R; Portnow, J; Reckamp, K; Shibata, S; Synold, TW; Twardowski, P | 1 |
| Abasq, C; Charles-Pétillon, F; Coat, C; De Braekeleer, M; Marcorelles, P; Quintin-Roué, I; Talagas, M; Uguen, A | 1 |
| Hu, L; Huang, YH; Wen, XP | 1 |
| Beresneva, IA; Gershanovich, ML; Makhnova, EV | 1 |
| Aravantinos, G; Bafaloukos, D; Bamias, A; Carina, M; Christodoulou, C; Klouvas, G; Linardou, H; Skarlos, D | 1 |
| Di Lauro, V; Freschi, A; La Mura, N; Nigri, P; Scalone, S; Veronesi, A; Zanetti, M | 1 |
| Hong, YK; Jeun, SS; Kang, JK; Kim, MC; Kim, MK; Lee, KS; Lee, TK; Park, CK; Yang, SH | 1 |
| Arun, B; Broglio, K; Buchholz, T; Francis, D; Groves, M; Hortobagyi, GN; Meyers, C; Rivera, E; Valero, V; Yin, G | 1 |
| Geng, Y; Li, EX; Li, SM; Shang, JT; Shi, F; Wu, YY; Xu, Z; Zhang, YT | 1 |
| Chen, ZP; Mu, YG; Sai, K; Shi, HL; Yue, WY; Zhang, JP; Zhang, XH | 1 |
| Ashley, DM; Coleman, LT; Downie, PA; Heath, JA; Khaw, SL | 1 |
| Arlin, Z; Clarkson, BD; Gee, T; Kempin, S; Koziner, B; Lee, BJ; Myers, J; Nisce, LZ; Passe, S; Straus, DJ; Young, CW | 1 |
| Golbey, RB; Lynch, G; Magill, GB; Sordillo, P | 1 |
| Bolton, PM; Clunie, GJ; Dury, M; Furnival, CM; Gough, IR | 1 |
| Douglass, HO; Engstrom, PF; MacIntyre, JM; Mittelman, A; Muggia, F | 1 |
| Coquelin, JP; Cupissol, D; Metz, R; Rosenfeld, C; Sauvanet, JP; Serrou, B | 1 |
| Aschele, C; Campora, E; Chiara, S | 1 |
| Bonichon, F; Bui, BN; Chevallier, B; Chevreau, C; Cupissol, D; Fargeot, P; Krakowski, I; Maugard-Louboutin, C; Peny, AM; Thyss, A | 1 |
| Drechsler, S; Faerber, L; Fiedler, H; Garbe, C; Kuehne, KH; Landthaler, M; Schroeder, K; Tilgen, W | 1 |
| Bécouarn, Y; Brunet, R; Fonck, M; Ollivier, S | 1 |
| Aamdal, S; Andersson, R; Bjelkengren, G; Ingvar, C; Jungnelius, U; Karlsson, M; Malmström, P; Mattsson, J; Ringborg, U; Stierner, U; Westberg, R; Willman, K; Wist, E | 1 |
| Agarwala, SS; Baker, SD; Barrington, R; Britten, CD; Diab, SG; Eckardt, JR; Eckhardt, SG; Fraass, U; Hammond, LA; Johnson, T; Rowinsky, EK; Statkevich, P; Villalona-Calero, M; Von Hoff, DD | 1 |
| Ascierto, PA; Cellerino, R; Comella, G; Comella, P; Daponte, A; DeLena, M; Gravina, A; Marini, G; Melucci, MT; Palmieri, G | 1 |
| Achtelik, W; Dummer, R; Ellwanger, U; Fey, M; Garbe, C; Hauschild, A; Kaufmann, R; Linse, R; Mohr, P; Nashan, D; Sebastian, G; Seiter, S; Stolz, W; Tilgen, W; Ugurel, S; Ulrich, J | 1 |
| Brodowicz, T; Fazeny-Dörner, B; Marosi, C; Muhm, M; Veitl, M; Vogelsang, H; Wenzel, C; Zielinski, C | 1 |
| Cohen, FB; Custodio, MC; Decter, JA; Lippman, AJ | 1 |
| Abele, R; Alberto, P; Germano, G; Obrecht, JP; Wagenknecht, L | 1 |
| Hill, G; Johnson, RO; Krementz, E; Metter, G; Wilson, W | 1 |
| Costanzi, JJ | 1 |
| Hodges, C; Legha, SS; Ring, S | 1 |
| Basurto, C; Boschetti, E; Bracarda, S; Del Favero, A; Lupattelli, M; Picciafuoco, M; Roila, F; Sassi, M; Tonato, M | 1 |
| Bayliss, MA; Chong, SL; Retsas, S; Sagar, SM | 1 |
| Ballatori, E; Basurto, C; Buzzi, F; Calabresi, F; Del Favero, A; Roila, F; Tonato, M | 1 |
| Wilman, DE | 1 |
| Bellet, RE; Berd, D; Mastrangelo, MJ; McClay, EF | 1 |
| Gundersen, S | 1 |
| Gundersen, S; Hager, B; Tausjø, J | 1 |
| Brunet, R; Bui, NB; Chauvergne, J; Coindre, JM; Durand, M; Hocke, C | 1 |
3 review(s) available for dacarbazine and Nausea
| Article | Year |
|---|---|
The safety of the temozolomide in patients with malignant glioma.
Topics: Adult; Antineoplastic Agents, Alkylating; Child; Clinical Trials as Topic; Dacarbazine; Drug Interactions; Glioma; Hematologic Diseases; Humans; Infections; Nausea; Temozolomide; Vomiting | 2006 |
The safety of temozolomide in the treatment of malignancies.
Topics: Antineoplastic Agents, Alkylating; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Humans; Lymphopenia; Nausea; Neoplasms; Neutropenia; Radiotherapy; Temozolomide; Thrombocytopenia; Vomiting | 2009 |
New antineoplastic drugs and their proper use.
Topics: Antineoplastic Agents; Asparaginase; Azacitidine; Bleomycin; Bone Marrow Diseases; Dacarbazine; Doxorubicin; Humans; Liver; Nausea; Neoplasms; Nitrosourea Compounds; Pancreatitis; Pulmonary Fibrosis; Vomiting | 1976 |
30 trial(s) available for dacarbazine and Nausea
| Article | Year |
|---|---|
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation.
Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; GTP Phosphohydrolases; Humans; Membrane Proteins; Middle Aged; Mutation; Nausea; Neoplasm Metastasis; Promoter Regions, Genetic; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Retreatment; Survival Rate; Temozolomide; Thrombocytopenia; Treatment Outcome; Tumor Suppressor Proteins; Vomiting | 2017 |
Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Constipation; CpG Islands; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nausea; Prognosis; Promoter Regions, Genetic; Treatment Outcome; Tumor Suppressor Proteins | 2013 |
Phase II study on EANI combined with hydrochloride palonosetron for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Electric Stimulation Therapy; Epirubicin; Humans; Ifosfamide; Isoquinolines; Middle Aged; Nausea; Neoplasms; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Vomiting; Young Adult | 2014 |
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.
Topics: Adult; Aged; Alanine Transaminase; Anilides; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Astrocytoma; Brain Neoplasms; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Constipation; Dacarbazine; Diarrhea; Fatigue; Female; Glioblastoma; Humans; Hypertension; L-Lactate Dehydrogenase; Leukopenia; Maintenance Chemotherapy; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasm Grading; Neurosurgical Procedures; Neutropenia; Pyridines; Temozolomide; Thrombocytopenia; Treatment Outcome | 2016 |
Phase 1 Study of Preoperative Chemoradiation Therapy With Temozolomide and Capecitabine in Patients With Locally Advanced Rectal Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Dacarbazine; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Preoperative Care; Rectal Neoplasms; Temozolomide; Treatment Outcome; Vomiting | 2016 |
Evaluation of the exposure equivalence of oral versus intravenous temozolomide.
Topics: Administration, Oral; Adult; Anemia; Antineoplastic Agents, Alkylating; Area Under Curve; Central Nervous System Neoplasms; Constipation; Cross-Over Studies; Dacarbazine; Drug Administration Schedule; Female; Headache; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Temozolomide; Therapeutic Equivalency; Time Factors; Vomiting | 2010 |
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents, Alkylating; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glioblastoma; Humans; Isoquinolines; Male; Middle Aged; Nausea; Palonosetron; Quinuclidines; Serotonin Antagonists; Temozolomide; Vomiting | 2011 |
A phase I study of bortezomib and temozolomide in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Boronic Acids; Bortezomib; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Induction; Fatigue; Female; Humans; Liver; Lymphopenia; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Neoplasms; Pyrazines; Temozolomide; Treatment Outcome; Young Adult | 2012 |
[Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Male; Mesna; Middle Aged; Nausea; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Vomiting | 2002 |
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study.
Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cisplatin; Dacarbazine; Female; Humans; Leukopenia; Lung Neoplasms; Male; Melanoma; Middle Aged; Nausea; Stomach Neoplasms; Temozolomide; Treatment Outcome | 2005 |
Combined chemoimmunotherapy of metastatic melanoma: a single institution experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dacarbazine; Female; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Melanoma; Nausea; Neutropenia; Recombinant Proteins; Skin Neoplasms; Survival Analysis; Thrombocytopenia; Vinblastine; Vomiting | 2005 |
Temozolomide chemotherapy in patients with recurrent malignant gliomas.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Dacarbazine; Drug Administration Schedule; Female; Glioma; Humans; Leukopenia; Magnetic Resonance Imaging; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Survival Analysis; Temozolomide; Treatment Outcome; Vomiting | 2006 |
Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Capecitabine; Cohort Studies; Dacarbazine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Humans; Middle Aged; Nausea; Temozolomide; Treatment Outcome; Vomiting | 2006 |
The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report.
Topics: Adolescent; Adult; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Nausea; Neuritis; Prednisone; Procarbazine; Prognosis; Time Factors; Vinblastine; Vincristine; Vomiting | 1980 |
Controlled study with imidazole carboxamide (DTIC), DTIC + bacillus Calmette-Guérin (BCG), and DTIC + corynebacterium parvum in advanced malignant melanoma. W.H.O. Collaborating Centres for Evaluation of Methods of Diagnosis and Treatment of Melanoma.
Topics: Bacterial Vaccines; BCG Vaccine; Brain Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Female; Fever; Humans; Leukopenia; Male; Melanoma; Middle Aged; Nausea; Propionibacterium acnes; Sex Factors; Time Factors | 1984 |
A trial of imidazole carboxamide and corynebacterium parvum in disseminated melanoma: clinical and immunologic results.
Topics: Bacterial Vaccines; Clinical Trials as Topic; Dacarbazine; Female; Humans; Immunotherapy; Injections, Intramuscular; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Pancytopenia; Prognosis; Propionibacterium acnes; Skin Neoplasms; Vomiting | 1980 |
Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275).
Topics: Antineoplastic Agents; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hydroxyurea; Male; Middle Aged; Nausea; Rectal Neoplasms; Semustine; Thrombocytopenia; Vincristine | 1982 |
Ondansetron for the control of dacarbazine-induced emesis.
Topics: Aged; Antiemetics; Antineoplastic Agents; Dacarbazine; Humans; Middle Aged; Nausea; Ondansetron; Vomiting | 1995 |
Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Double-Blind Method; Doxorubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematuria; Hemoglobins; Humans; Ifosfamide; Injections, Subcutaneous; Length of Stay; Lenograstim; Leukocyte Count; Male; Mesna; Middle Aged; Nausea; Neutropenia; Platelet Count; Recombinant Proteins; Regression Analysis; Sarcoma; Soft Tissue Neoplasms; Stomatitis | 1995 |
Dose comparison of tropisetron (Navoban) 5 mg and 10 mg orally in the prophylaxis of dacarbazine-induced nausea and emesis.
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Dacarbazine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Indoles; Male; Melanoma; Middle Aged; Nausea; Quality of Life; Serotonin Antagonists; Tropisetron; Vomiting | 1994 |
Dacarbazine, fluorouracil, and leucovorin in patients with advanced neuroendocrine tumors: a phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Dacarbazine; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Nausea; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Survival Rate | 1998 |
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Nausea; Prospective Studies; Regression Analysis; Skin Neoplasms; Survival Analysis; Treatment Outcome; Vindesine; Vomiting | 1998 |
A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Neoplasm Staging; Neoplasms; Neutropenia; Temozolomide; Treatment Outcome; Vomiting | 1999 |
Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
Topics: Adult; Aged; Anemia; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; CD146 Antigen; Cisplatin; Dacarbazine; Female; Fever; Follow-Up Studies; Humans; Interferon-alpha; Male; MART-1 Antigen; Melanoma; Melanoma-Specific Antigens; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Nausea; Neoplasm Proteins; Neural Cell Adhesion Molecules; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting | 2000 |
Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chills; Dacarbazine; Female; Fever; Follow-Up Studies; Hematologic Diseases; Humans; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Nausea; Remission Induction; Survival Analysis; Treatment Outcome; Vomiting | 2001 |
Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.
Topics: Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leukopenia; Lomustine; Male; Melanoma; Middle Aged; Nausea; Sex Factors; Thrombocytopenia; Triazenes; Vincristine; Vomiting | 1976 |
DTIC (NSC-45388) studies in the southwest oncology group.
Topics: Carmustine; Chlorpromazine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Melanoma; Nausea; Neoplasm Metastasis; Remission, Spontaneous; Thrombocytopenia; Triazenes; Vincristine; Vomiting | 1976 |
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dexamethasone; Diphenhydramine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Melanoma; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Sarcoma; Vomiting | 1992 |
Antiemetic activity of high-dose metoclopramide combined with methylprednisolone versus metoclopramide alone in dacarbazine-treated cancer patients. A randomized double-blind study of the Italian Oncology Group for Clinical Research.
Topics: Dacarbazine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Prospective Studies; Random Allocation; Vomiting | 1989 |
Analysis of a series of sixty soft tissue sarcomas in adults treated with a cyclophosphamide-vincristine-adriamycin-dacarbazine (CYVADIC) combination.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms; Thrombocytopenia; Vincristine | 1985 |
26 other study(ies) available for dacarbazine and Nausea
| Article | Year |
|---|---|
Correlations of MGMT genetic polymorphisms with temozolomide resistance and prognosis of patients with malignant gliomas: a population-based study in China.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Asian People; Brain Neoplasms; China; Dacarbazine; Drug Resistance, Neoplasm; Female; Genotype; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nausea; O(6)-Methylguanine-DNA Methyltransferase; Polymorphism, Genetic; Prognosis; Temozolomide; Vomiting | 2017 |
Durable response of intracranial cellular hemangioma to bevacizumab and temozolomide.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Dacarbazine; Headache; Hemangioma, Capillary; Humans; Magnetic Resonance Imaging; Male; Nausea; Neoplasm Recurrence, Local; Neurosurgical Procedures; Temozolomide; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vomiting | 2013 |
Toxicity profile of temozolomide in the treatment of 300 malignant glioma patients in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Glioma; Hematologic Diseases; Humans; Male; Middle Aged; Nausea; Neoplasm Staging; Republic of Korea; Retrospective Studies; Severity of Illness Index; Sex Factors; Temozolomide; Vomiting; Young Adult | 2014 |
Profile Analysis of Chemotherapy-induced Nausea and Vomiting in Patients Treated with Concomitant Temozolomide and Radiotherapy: Results of a Prospective Study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Chemoradiotherapy; Dacarbazine; Female; Glioma; Humans; Male; Middle Aged; Nausea; Prospective Studies; Temozolomide; Vomiting; Young Adult | 2015 |
Case of hypophysitis caused by nivolumab.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Anorexia; Antibodies, Monoclonal; Antineoplastic Agents; Conjunctiva; Dacarbazine; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypophysitis; Hypothyroidism; Lung Diseases, Interstitial; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Myalgia; Nausea; Nivolumab; Programmed Cell Death 1 Receptor; Withholding Treatment | 2017 |
Combination of Palonosetron, Aprepitant, and Dexamethasone Effectively Controls Chemotherapy-induced Nausea and Vomiting in Patients Treated with Concomitant Temozolomide and Radiotherapy: Results of a Prospective Study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents, Alkylating; Aprepitant; Brain Neoplasms; Dacarbazine; Dexamethasone; Drug Therapy, Combination; Female; Glioma; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Palonosetron; Prospective Studies; Quinuclidines; Serotonin Antagonists; Temozolomide; Vomiting | 2016 |
Efficacy of temozolomide for recurrent embryonal brain tumors in children.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Headache; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Nausea; Neuroectodermal Tumors, Primitive; Rhabdoid Tumor; Temozolomide; Teratoma; Treatment Outcome; Vomiting | 2009 |
Management of temozolomide toxicity by nurse practitioners in neuro-oncology.
Topics: Analysis of Variance; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chi-Square Distribution; Dacarbazine; Drug Administration Schedule; Drug Monitoring; Glioma; Humans; Lymphopenia; Nausea; Netherlands; Neutropenia; Nurse Practitioners; Nurse's Role; Nursing Evaluation Research; Oncology Nursing; Prospective Studies; Statistics, Nonparametric; Temozolomide; Thrombocytopenia; Treatment Outcome; Vomiting | 2009 |
Preoperative intensity-modulated radiotherapy combined with temozolomide for locally advanced soft-tissue sarcoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Female; Humans; Male; Middle Aged; Nausea; Postoperative Complications; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Remission Induction; Sarcoma; Temozolomide; Tumor Burden; Vomiting | 2009 |
[Nimotuzumab in combination with chemotherapy for patients with malignant gliomas].
Topics: Adolescent; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Child; Cisplatin; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Glioma; Humans; Infusions, Intravenous; Male; Nausea; Neutropenia; Nimustine; Temozolomide; Teniposide; Thrombocytopenia; Young Adult | 2011 |
Single dose palonosetron and dexamethasone in preventing nausea and vomiting induced by high emetogenic ABVD regimen in Hodgkin Lymphoma patients.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Isoquinolines; Male; Middle Aged; Nausea; Palonosetron; Prospective Studies; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vinblastine; Vomiting; Young Adult | 2012 |
[A silent-growing and fast-killing melanoma in a teenager].
Topics: Adolescent; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Back Pain; Combined Modality Therapy; Cyclin D1; Dacarbazine; Drug Resistance, Neoplasm; Fatal Outcome; Female; Gene Amplification; Head and Neck Neoplasms; Humans; Immunotherapy; In Situ Hybridization, Fluorescence; Ipilimumab; Lymphatic Metastasis; Melanoma; Nausea; Neoplasm Proteins; Neoplasms, Second Primary; Nevus; Osteolysis; Scalp; Skin Neoplasms; Weight Loss | 2012 |
[Novel pharmacologic form of ondansetron (Zofran)--lingual tablets in the prevention of cytostatic chemotherapy-induced loss of appetite, nausea and vomiting].
Topics: Administration, Sublingual; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Appetite; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Male; Middle Aged; Nausea; Ondansetron; Prednisone; Tablets; Treatment Outcome; Vinblastine; Vincristine; Vomiting | 2003 |
[Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Fibrosarcoma; Follow-Up Studies; Humans; Ifosfamide; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Remission Induction; Rhabdomyosarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Survival Rate; Thrombocytopenia; Young Adult | 2006 |
[Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nausea; Neutropenia; O(6)-Methylguanine-DNA Methyltransferase; Remission Induction; Temozolomide; Young Adult | 2006 |
Temozolomide in pediatric low-grade glioma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Female; Hematologic Diseases; Humans; Male; Nausea; Radiography; Retrospective Studies; Spinal Cord Neoplasms; Survival Rate; Temozolomide; Vincristine | 2007 |
Combination chemotherapy of advanced sarcomas in adults with "CYOMAD" (S7).
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Heart Diseases; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Nausea; Sarcoma; Vincristine; Vomiting | 1982 |
Cipropride in preventing nausea and vomiting induced by severely emetic cytostatic agents.
Topics: Adult; Antiemetics; Antineoplastic Agents; Cisplatin; Dacarbazine; Female; Humans; Male; Middle Aged; Nausea; Pyrrolidines; Vomiting | 1981 |
Alterations in intestinal permeability following the intensified polydrug-chemotherapy IFADIC (ifosfamide, Adriamycin, dacarbazine).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Intestinal Mucosa; Intestines; Male; Middle Aged; Nausea; Permeability; Sarcoma; Vomiting | 2002 |
[Simultaneous combination of adriamycin, bleomycin, cyclohexyl-chloroethyl nitrosourea with dimethyl-triazeno imidazole carboxamide in the treatment of Hodgkin's lymphoma].
Topics: Adult; Bleomycin; Bone Marrow; Bone Marrow Cells; Dacarbazine; Dermatitis, Exfoliative; Doxorubicin; Drug Therapy, Combination; Female; Fever; Hodgkin Disease; Humans; Male; Nausea; Nitrosourea Compounds; Remission, Spontaneous; Stomatitis; Triazenes; Vomiting | 1976 |
Efficacy of ondansetron against nausea and vomiting caused by dacarbazine-containing chemotherapy.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Humans; Imidazoles; Male; Melanoma; Middle Aged; Nausea; Ondansetron; Vinblastine; Vomiting | 1992 |
Ondansetron; further progress in the prevention of nausea and vomiting induced by anti-cancer chemotherapy.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dacarbazine; Humans; Imidazoles; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1991 |
Prodrugs in cancer chemotherapy.
Topics: Altretamine; Aniline Mustard; Animals; Antineoplastic Agents; Azo Compounds; Biotransformation; Chemistry, Pharmaceutical; Cyclophosphamide; Dacarbazine; Drug Evaluation; Female; Galactosidases; Glucuronosyltransferase; Humans; Imidazoles; Liver; Male; Nausea; Neoplasms; Neoplasms, Experimental; Structure-Activity Relationship; Temozolomide; Vomiting | 1986 |
Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Dacarbazine; Female; Humans; Kidney Diseases; Leukopenia; Male; Melanoma; Middle Aged; Nausea; Pulmonary Embolism; Skin Neoplasms; Tamoxifen; Thrombocytopenia; Thromboembolism; Vomiting | 1987 |
Dacarbazine, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Dacarbazine; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Nausea; Vindesine; Vomiting | 1987 |
Radiation in combination with intra-arterial infusion therapy with dacarbazine for metastatic malignant melanoma localized to a lower extremity.
Topics: Aged; Combined Modality Therapy; Dacarbazine; Female; Humans; Leg; Male; Melanoma; Middle Aged; Nausea; Neoplasm Recurrence, Local; Radiography; Skin Neoplasms | 1986 |